Atrium Therapeutics Reports First Quarter 2026 Financial Results
Go back to Atrium Therapeutics Reports First Quarter 2026 Financial Results| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 8.26 -0.07 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.33 | 52 Week High | $22.80 | |||
| Open | $8.30 | 52 Week Low | $4.12 | |||
| Day High | $8.49 | P/E | N/A | |||
| Day Low | $8.20 | EPS | $0.00 | |||
| Volume | 187,720 | |||||
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 8.26 -0.07 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.33 | 52 Week High | $22.80 | |||
| Open | $8.30 | 52 Week Low | $4.12 | |||
| Day High | $8.49 | P/E | N/A | |||
| Day Low | $8.20 | EPS | $0.00 | |||
| Volume | 187,720 | |||||

